Cellectar Biosciences, Inc. Shareholders' Equity
Cellectar Biosciences, Inc. (CLRB) had Shareholders' Equity of $29.87 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $29.87M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.34M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $8.54M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $8.00M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $29.87M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.34M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $8.54M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $8.00M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.09M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $8.25M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $14.29M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $15.16M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $12.38M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $12.50M 10-Q · filed 2025-11-13 | $26.17M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$15.16M 10-K · filed 2026-03-04 | -$1.36M 10-K · filed 2024-03-27 |
| 2023-09-30 | -$28.00M 10-Q · filed 2024-11-18 | -$13.35M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$8.39M 10-Q · filed 2024-11-18 | -$467.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.37M 10-Q · filed 2024-11-18 | $7.33M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $8.15M 10-K · filed 2025-03-13 | $15.51M 10-K · filed 2023-03-09 |
| 2022-09-30 | $10.77M 10-K/A · filed 2024-10-29 | $12.75M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $17.91M 10-K/A · filed 2024-10-29 | $20.19M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $23.13M 10-K/A · filed 2024-10-29 | $27.21M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $29.06M 10-K/A · filed 2024-10-29 | $33.05M 10-K · filed 2022-03-21 |
| 2021-09-30 | $38.59M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $43.98M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $49.78M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $54.79M 10-K · filed 2023-03-09 | |
| 2020-09-30 | $16.22M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $19.99M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $5.25M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $9.06M 10-K · filed 2022-03-21 | |
| 2019-09-30 | $12.23M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $15.99M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $9.85M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $13.26M 10-K · filed 2021-03-02 | |
| 2018-09-30 | $16.88M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $4.71M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $7.45M 10-Q · filed 2019-11-12 | $7.45M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $10.75M 10-K · filed 2020-03-09 | |
| 2017-09-30 | $7.59M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $10.86M 10-Q · filed 2018-11-13 | |
| 2017-03-31 | $13.75M 10-Q · filed 2018-11-13 | |
| 2016-12-31 | $13.54M 10-K · filed 2019-02-26 | |
| 2016-09-30 | $7.72M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $9.83M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $2.58M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $1.65M 10-K · filed 2018-03-21 | |
| 2015-09-30 | $680.15K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $2.37M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $4.59M 10-Q · filed 2015-05-20 | |
| 2014-12-31 | $6.70M 10-K · filed 2017-03-15 | $10.75M 10-K · filed 2015-03-24 |
| 2014-09-30 | $9.88M 10-Q · filed 2015-05-20 | $13.15M 10-Q · filed 2014-11-12 |
| 2014-06-30 | -$2.54M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | -$727.31K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $1.70M 10-K/A · filed 2016-10-20 | |
| 2013-09-30 | $4.43M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $5.44M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $7.13M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $10.16M 10-K · filed 2015-05-20 | |
| 2012-09-30 | $9.07M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $10.63M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $7.56M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $9.48M 10-K · filed 2014-03-19 | |
| 2011-09-30 | $5.90M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $7.41M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $133.76K 10-K · filed 2014-03-19 | |
| 2009-12-31 | $4.13M 10-K · filed 2014-03-19 | |
| 2008-12-31 | $9.84M 10-K · filed 2014-03-19 | |
| 2007-12-31 | $2.53M 10-K · filed 2014-03-19 | |
| 2006-12-31 | $6.55M 10-K · filed 2014-03-19 | |
| 2005-12-31 | $400.21K 10-K · filed 2014-03-19 | |
| 2004-12-31 | $46.17K 10-K · filed 2014-03-19 | |
| 2003-12-31 | $388.94K 10-K · filed 2014-03-19 | |
| 2002-12-31 | $599.38K 10-K · filed 2014-03-19 | |
| 2002-11-06 | $0.00 10-K · filed 2014-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |